GEODE CAPITAL MANAGEMENT, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$13,087,503
-7.8%
512,168
+3.4%
0.00%0.0%
Q2 2023$14,201,647
+26.6%
495,176
+5.8%
0.00%
+100.0%
Q1 2023$11,220,740
+146960.8%
468,116
+4.0%
0.00%0.0%
Q4 2022$7,630
-99.9%
449,939
+8.0%
0.00%0.0%
Q3 2022$6,176,000
-0.0%
416,791
+6.2%
0.00%0.0%
Q2 2022$6,178,000
-38.2%
392,537
+5.8%
0.00%0.0%
Q1 2022$10,001,000
-28.0%
370,983
-1.1%
0.00%
-50.0%
Q4 2021$13,882,000
-27.4%
375,113
-6.3%
0.00%
-33.3%
Q3 2021$19,129,000
+47.4%
400,369
+4.4%
0.00%
+50.0%
Q2 2021$12,981,000
-11.7%
383,617
+7.8%
0.00%0.0%
Q1 2021$14,698,000
+4.4%
355,896
+9.7%
0.00%0.0%
Q4 2020$14,072,000
+21.7%
324,396
+20.4%
0.00%0.0%
Q3 2020$11,562,000
+16.6%
269,534
+27.0%
0.00%0.0%
Q2 2020$9,917,000
+725.7%
212,201
+139.8%
0.00%
Q1 2020$1,201,000
-34.6%
88,487
-47.6%
0.00%
Q4 2019$1,836,000
+127.2%
168,990
+114.6%
0.00%
Q3 2019$808,000
+536.2%
78,750
+484.5%
0.00%
Q2 2019$127,00013,4730.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders